TRPM2 and hepatocellular carcinoma: There is suggestive evidence that TRPM2 channel activity may be altered in steatotic hepatocytes and hence may contribute to the progression of non-alcoholic fatty liver disease to cirrhosis and hepatocellular carcinoma [93].